(Q77166127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

1 reference

D J Trepanier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

H Gallant

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D F Legatt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R W Yatscoff

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

published in

Clinical Biochemistry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

345-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Rapamycin efficacy is blood level related

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Population pharmacokinetics of sirolimus in kidney transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Blood distribution of rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Determination of rapamycin in whole blood by HPLC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Radioreceptor assay for sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Chronic cyclosporine-induced nephrotoxicity: a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Sirolimus: a new agent for clinical renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

Preclinical evaluation of a new potent immunosuppressive agent, rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of in vitro immunoglobulin production by rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900048-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(98)00048-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9721433%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference